Literature DB >> 20453703

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.

Pritesh Patel1, Veena Nandwani, John Vanchiere, Steven A Conrad, L Keith Scott.   

Abstract

OBJECTIVE: Acute pneumonitis with acute lung injury is a cause of significant mortality related to the 2009 pH1N1 influenza A virus. Widespread lung inflammation and increased pulmonary vascular permeability has been noted on autopsy. Also, many of these patients present with significant hemodynamic compromise suggesting systemic cytokine release. Therefore, attenuating circulating cytokines, and other mediators, by blood purification techniques is a theoretically attractive strategy. We report the use therapeutic plasma exchange in three children with 2009 H1N1 related acute lung injury with severe hemodynamic compromise that had failed conventional therapeutic interventions.
DESIGN: Case series.
SETTING: Pediatric intensive care unit in a university children's hospital. PATIENTS: Three children, aged 8, 11, and 17 yrs, with acute respiratory distress syndrome and hemodynamic compromise related to the 2009 pH1N1 influenza A virus documented by polymerase chair reaction. All patients were on mechanical ventilation and inhaled nitric oxide, and one patient was on extracorporeal membrane oxygenation. Therapeutic plasma exchange was used as a rescue strategy.
INTERVENTIONS: Each patient received three exchanges of 35-40 mL/kg on consecutive days. MEASUREMENTS: All three patients had dramatic reduction in pediatric logistic organ dysfunction scores, oxygen requirements, and vasopressor requirements after two exchanges. All survived with good functional recovery. MAIN
RESULTS: In this small series of patients with H1N1/acute respiratory distress syndrome and hemodynamic compromise, therapeutic plasma exchange appeared to benefit as a method of mitigating the associated cytokine storm. The procedure was well tolerated with no reported side effects. All three patients survived, defying the predicted mortality. Because these procedures used the filtration exchange method, it was performed in a timely fashion by intensive care unit personnel and on equipment already available in the intensive care unit for renal support.
CONCLUSIONS: This very limited case series suggest there may be a role for therapeutic plasma exchange as a rescue therapy in severe shock and acute lung injury related to pH1N1 that has not responded to traditional therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20453703      PMCID: PMC6328374          DOI: 10.1097/PCC.0b013e3181e2a569

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  14 in total

Review 1.  Extracorporeal therapies in the treatment of sepsis: experience and promise.

Authors:  James D Fortenberry; Matthew L Paden
Journal:  Semin Pediatr Infect Dis       Date:  2006-04

2.  Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.

Authors:  Rolf Busund; Vladimir Koukline; Uri Utrobin; Edvard Nedashkovsky
Journal:  Intensive Care Med       Date:  2002-07-23       Impact factor: 17.440

Review 3.  Acute respiratory distress syndrome as a major clinical manifestation of thrombotic thrombocytopenic purpura.

Authors:  J C Chang; E S Aly
Journal:  Am J Med Sci       Date:  2001-02       Impact factor: 2.378

Review 4.  A review of plasma exchange in sepsis.

Authors:  John H Reeves
Journal:  Blood Purif       Date:  2002       Impact factor: 2.614

5.  Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.

Authors:  Bernd G Stegmayr; Ravjet Banga; Lars Berggren; Rut Norda; Anders Rydvall; Tomas Vikerfors
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

6.  Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.

Authors:  Trung C Nguyen; Yong Y Han; Joseph E Kiss; Mark W Hall; Andrea Cortese Hassett; Ron Jaffe; Richard A Orr; Janine Janosky; Joseph A Carcillo
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

7.  Effect of plasmapheresis on the immune system in endotoxin-induced sepsis.

Authors:  P Toft; R Schmidt; A C Broechner; B U Nielsen; P Bollen; K E Olsen
Journal:  Blood Purif       Date:  2008-01-22       Impact factor: 2.614

Review 8.  Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury.

Authors:  Andrew A House; Claudio Ronco
Journal:  Blood Purif       Date:  2008-01-10       Impact factor: 2.614

9.  Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy.

Authors:  Joseph V DiCarlo; Steven R Alexander; Rajni Agarwal; Joshua D Schiffman
Journal:  J Pediatr Hematol Oncol       Date:  2003-10       Impact factor: 1.289

10.  Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis.

Authors:  C Yu; Z-H Liu; Z-H Chen; D H Gong; D-X Ji; L S H Li
Journal:  Int J Artif Organs       Date:  2008-10       Impact factor: 1.595

View more
  24 in total

1.  An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.

Authors:  Abdolkarim Sheikhi; Mohammad Hojjat-Farsangi
Journal:  Hum Vaccin Immunother       Date:  2020-07-14       Impact factor: 3.452

Review 2.  Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors:  Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal:  Expert Rev Clin Immunol       Date:  2020-11-25       Impact factor: 4.473

3.  Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.

Authors:  Gopal K Patidar; Kevin J Land; Hans Vrielink; Naomi Rahimi-Levene; Eldad J Dann; Hind Al-Humaidan; Steven L Spitalnik; Yashaswi Dhiman; Cynthia So-Osman; Salwa I Hindawi
Journal:  Vox Sang       Date:  2021-03-17       Impact factor: 2.996

Review 4.  The role of adjuvant immunomodulatory agents for treatment of severe influenza.

Authors:  David S Hui; Nelson Lee; Paul K Chan; John H Beigel
Journal:  Antiviral Res       Date:  2018-01-08       Impact factor: 5.970

5.  First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.

Authors:  Klaus Stahl; Christian Bode; Sascha David
Journal:  Crit Care       Date:  2020-06-18       Impact factor: 9.097

Review 6.  Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.

Authors:  Seena Tabibi; Tara Tabibi; Rosalynn R Z Conic; Nassim Banisaeed; Michael B Streiff
Journal:  J Intensive Care Med       Date:  2020-07-15       Impact factor: 3.510

7.  Therapeutic plasma exchange in adults with severe COVID-19 infection.

Authors:  Faryal Khamis; Ibrahim Al-Zakwani; Sabria Al Hashmi; Samata Al Dowaiki; Maher Al Bahrani; Nenad Pandak; Huda Al Khalili; Ziad Memish
Journal:  Int J Infect Dis       Date:  2020-06-23       Impact factor: 3.623

8.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542

9.  Severe influenza treatment guideline.

Authors:  Won Suk Choi; Ji Hyeon Baek; Yu Bin Seo; Sae Yoon Kee; Hye Won Jeong; Hee Young Lee; Byung Wook Eun; Eun Ju Choo; Jacob Lee; Young Keun Kim; Joon Young Song; Seong-Heon Wie; Jin Soo Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

Review 10.  How to approach and treat viral infections in ICU patients.

Authors:  Theodoros Kelesidis; Ioannis Mastoris; Aliki Metsini; Sotirios Tsiodras
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.